Rentschler Biopharma is pleased to announce the successful completion of the inspection of its manufacturing facility by the UK Medicines & Healthcare products Regulatory Agency. The contract development organization (CDMO) for biopharmaceuticals has received manufacturing authorization from the MHRA. The ATMP...
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced that its long-standing client, Chiesi Group, recently presented Rentschler Biopharma with the “We Excel in Innovation and Collaboration Award”. During Chiesi Group’s Vendor Day,...
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, is expanding its Leadership Team with two experienced leaders in the areas of strategy and law. These newly created internal advisory functions will play an important role in the continued...
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) provided an update on progress at Rentschler ATMP Ltd., the Company’s dedicated cell and gene therapy facility located in Stevenage, UK, including an important key hire. The Company has recently hired Kassim Kolia as Vice...
